SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 205.22-0.8%12:13 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: squetch who wrote (20515)5/11/1998 9:12:00 PM
From: Torben Noerup Nielsen  Read Replies (1) of 32384
 
Squetch,

>Huh? Here is what SRGN lists as side-effects. Bear in mind 37%
>withdrawal b/c of adverse events The last line doesn't instill
>confidence in me.

This *is* cancer. By far the most common side effect of non-treatment is an unpleasant demise....

Also, there is a real problem with cancer trials. They naturally tent to enroll patients whose entire systems are already severely compromised due to the disease *and* due to unsuccessfull prior treatments.

Torben
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext